A living library of credible information for patients of multiple myeloma and their caregivers.
…
continue reading
Multiple Myeloma Patients Podcasts
The International Myeloma Foundation (IMF) is the world’s first and largest myeloma organization, reaching more than 525,000 members in 140 countries. Founded in 1990, the IMF is a non-profit organization dedicated to improving the quality of life of myeloma patients and their families. The IMF funds research, provides education, lends support, and promotes advocacy initiatives that allow collective voices to be heard. The IMF’s dedicated and diverse staff provides immediate help. Our knowle ...
…
continue reading
The Multiple Myeloma Research Foundation provides educational programs to help people with myeloma, family members, caregivers, and healthcare professionals learn more about the disease and today's most promising treatment options, including clinical trials, from leading multiple myeloma doctors and researchers.
…
continue reading
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
…
continue reading
Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
…
continue reading
Emergency Medicine Cases – Where the Experts Keep You in the Know. For show notes, quizzes, videos and more learning tools please visit emergencymedicinecases.com
…
continue reading
CancerCare's free Connect Education Workshops are a way for people to learn about cancer-related issues from the convenience of their home or office. Leading experts in oncology provide the most up-to-date information in these workshops to help you and your loved ones better understand and cope with your cancer diagnosis, treatment options, quality-of-life concerns, treatment side effects, pain management, doctor-patient communication and other important topics.
…
continue reading
Wait How Do You Spell That? is a rare disease podcast produced by Patient Worthy. We talk about issues affecting people rare and underdiagnosed conditions and interview advocates from across the community. We‘re definitely not doctors, and we can‘t give you medical advice. We‘re just here to chat and learn about the diseases that even doctors can‘t seem to spell. Check out the latest in rare disease news at PatientWorthy.com.
…
continue reading
Physicians' Education Resource® (PER®) is committed to advancing patient care through professional education. This podcast is a natural extension of PER®'s efforts to provide medical education for health care providers to stay up to date with advances in medical care, from diagnosis through treatment, with the ultimate goal of improving patient outcomes. Visit www.gotoper.com for more information.
…
continue reading
Sit back and listen to Ulf-Henrik Mellqvist talking about the significant developments in the field of multiple myeloma treatment. What do the new possibilities mean for patients and doctors? And why should young doctors looking to specialize go into hematology?
…
continue reading

1
PeerView Heart, Lung & Blood CME/CNE/CPE Audio Podcast
PVI, PeerView Institute for Medical Education
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
…
continue reading

1
PeerView Heart, Lung & Blood CME/CNE/CPE Video Podcast
PVI, PeerView Institute for Medical Education
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
…
continue reading
Welcome to the Clinical Care Solutions Oncology podcast channel. Our podcast shows give you quick access to important content when you need it - at home, at your desk, or on the go.
…
continue reading
Podcast by Managed Care Cast
…
continue reading
Have you ever been talking with other surgeons about the way they do things in their practice and you heard something that helped you out? This podcast is meant to give you an insight into the way other surgeons do things and think about things. Sometimes small changes can make a big difference in your daily routine.
…
continue reading
The Blood Podcast summarizes content recently published in Blood, the most cited peer-reviewed publication in the field of hematology.
…
continue reading
Coming Home Well is a podcast hosted by Dr. Tyler Pieron, dedicated to exploring topics that support and uplift the veteran community. The show features engaging conversations with organizations working to assist veterans, discussions with historians about pivotal moments in military history, insights into claims and benefits for service members, and a wide range of other subjects relevant to veterans and their families. Through these discussions, the podcast provides valuable information, g ...
…
continue reading
Welcome to the mibo show, where we focus on mind and body wellness… let’s talk about it!!! Each episode our guests will talk about their mental and/or physical health journey or that of their family. We will also have subject matter experts talk health facts and stats, best practices for wellness, and provide strategies to encourage us all how to live a healthy lifestyle where we prioritize our mind and body wellness on a regular basis!
…
continue reading
The Cancer Revolution podcast series looks to explore all areas of integrative, traditional and alternative means of beating cancer and creating sustained good health, for the young folks and old. Our topics will include areas such as immune system, metabolic theory, epigenetic, microbial connections, diet, mitigating side effects of cancer treatments, detoxification methods, anticancer nutrition, the latest news and stories in institutional cancer research
…
continue reading
Audio-reports and interviews done in collaboration with Audio Medica and its founding Editor Peter Goodwin. Audio Medica's Audio Journal of Oncology has been bringing lively listen-in shows to members of the cancer care team in various audio formats since 1992. Scientific Editors are George Canellos, MD, of Dana-Farber Cancer Institute; J. Gordon McVie, MD, of the European Institute of Oncology and Chair of the Editorial Board of OT's UK Edition; Pat Price, MD, of Christie Hospital, also on ...
…
continue reading

1
Advancing the Care of Patients With High-Risk HR-Positive/HER2-Negative Early Breast Cancer
26:10
26:10
Play later
Play later
Lists
Like
Liked
26:10In this podcast episode, breast cancer experts Manali Bhave, MD, and Erin F. Cobain, MD, discuss their management of patients with HR-positive/HER2-negative early breast cancer including insights on identifying high-risk disease considering clinical/pathological factors and gene expression assays and answering healthcare professional questions on h…
…
continue reading

1
Advancing the Care of Patients With HR-Positive/HER2-Negative Metastatic Breast Cancer
23:57
23:57
Play later
Play later
Lists
Like
Liked
23:57In this podcast episode, breast cancer experts Manali Bhave, MD, and Erin F. Cobain, MD, discuss their management of patients with HR-positive/HER2-negative metastatic breast cancer including the current treatment algorithm, implementing genomic testing for assessing molecular resistance and guiding treatment decisions, and answering healthcare pro…
…
continue reading

1
HER2-Positive Gastroesophageal Adenocarcinoma and Biliary Tract Cancers: Testing Recommendations and New Treatment Options
37:10
37:10
Play later
Play later
Lists
Like
Liked
37:10In this podcast episode, Amit Mahipal, MD, MPH, and Shubham Pant, MD, discuss new and emerging therapies for the personalized care of patients with HER2-positive gastroesophageal adenocarcinoma (GEA) and biliary tract cancer (BTC), including: Brief overview of BTC and GEA Approved HER2-directed therapies for BTC and GEA and their mechanisms of acti…
…
continue reading

1
Streamlining Referrals: Software that Helps Intake and Track Referrals Efficiently (with Dr. Tom Stone)
34:07
34:07
Play later
Play later
Lists
Like
Liked
34:07Oral surgeons spend a lot of time focusing on getting referrals, only to lose approximately 50% of them to their competitors when they do not track them properly. Today on Everyay Oral Surgery, we welcome Dr. Tom Stone back to the show to discuss how to streamline referrals. Tuning in, you’ll hear all about the incredible Dr. Tock referral tracking…
…
continue reading

1
Follicular Lymphoma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual Meeting
59:34
59:34
Play later
Play later
Lists
Like
Liked
59:34Dr Jeremy S Abramson from Massachusetts General Hospital in Boston, Dr Jennifer Crombie from Dana-Farber Cancer Institute also in Boston and Dr Laurie H Sehn from the BC Cancer Centre for Lymphoid Cancer in Vancouver, British Columbia, Canada, discuss recent updates on available and novel treatment strategies for follicular lymphoma. CE informatio…
…
continue reading

1
Acute Myeloid Leukemia — An Interview with Dr Ghayas Issa on the Role of Menin Inhibitors
58:47
58:47
Play later
Play later
Lists
Like
Liked
58:47Dr Ghayas Issa from The University of Texas MD Anderson Cancer Center in Houston discusses data guiding the use of menin inhibitors for patients with acute myeloid leukemia and select alterations. CME information and select publications here.
…
continue reading

1
021 Understanding Risk in Myeloma: What Your Genetics Can Tell You
36:31
36:31
Play later
Play later
Lists
Like
Liked
36:31This episode unpacks the complex world of myeloma genetics - what high and standard risk really mean, how these tests guide treatment, and how future advances could lead to truly personalised care with Sarah Gooding. Sarah is a colleague, and an Honorary Consultant Haematologist, based in Oxford. 📌Key Takeaways: Your myeloma is unique - genetic tes…
…
continue reading

1
How Medicaid Reforms Could Deepen State Coverage Gaps
17:48
17:48
Play later
Play later
Lists
Like
Liked
17:48By Managed Care Cast
…
continue reading

1
EM Quick Hits 68 Osteomyelitis, Tourniquet Technique, Pediatric Distal Radius Buckle Fractures, DSI RCT, AMS in ESRD & Dialysis, EM Leadership Spotlight #3
1:25:12
1:25:12
Play later
Play later
Lists
Like
Liked
1:25:12By Dr. Anton Helman
…
continue reading

1
The Power of Personalized Gifts and Communication for Your Referring Doctors (with Dr. Vic Martel)
55:01
55:01
Play later
Play later
Lists
Like
Liked
55:01What turns a good referral relationship into a lifelong partnership? In this episode of Everyday Oral Surgery, Dr. Grant Stucki welcomes back Dr. Vic Martel to dive deep into the art of building loyalty with referring doctors. They explore why simply doing great clinical work is not enough and how personal touches, like remembering birthdays, anniv…
…
continue reading

1
Julie R. Brahmer, MD, MSc, FASCO - Maximizing the Potential and Expanding the Impact of Immunotherapy in Advanced NSCLC
1:01:33
1:01:33
Play later
Play later
Lists
Like
Liked
1:01:33This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/…
…
continue reading

1
Julie R. Brahmer, MD, MSc, FASCO - Maximizing the Potential and Expanding the Impact of Immunotherapy in Advanced NSCLC
1:01:33
1:01:33
Play later
Play later
Lists
Like
Liked
1:01:33This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/…
…
continue reading

1
Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual Meeting
58:29
58:29
Play later
Play later
Lists
Like
Liked
58:29Prof Meletios-Athanasios (Thanos) C Dimopoulos from Alexandra Hospital in Athens, Greece, Dr Hans Lee from Sarah Cannon Research Institute in Nashville, Tennessee, Dr Joseph Mikhael from City of Hope Cancer Center in Phoenix, Arizona, and Dr Noopur Raje from Massachusetts General Hospital in Boston discuss recent updates on available and novel trea…
…
continue reading
In this How I Treat podcast episode, Laura Michaelis, MD interviews Sung-Yun Pai, MD about their recently published article in Blood journal "How I treat Wiskott-Alrich syndrome". They highlight recent updates in treatment, including new risk-benefit calculations due to safer treatments and longer follow-ups. Challenges include late diagnosis, lack…
…
continue reading

1
Use of Marstacimab for Prophylaxis in hemophilia A and B; matched-donor allogeneic CD19 CAR-T in adult B-ALL; a new prognostic index for T-cell cutaneous lymphomas
19:43
19:43
Play later
Play later
Lists
Like
Liked
19:43In this week's episode we'll learn about targeting the tissue factor pathway inhibitor with a monoclonal antibody to rebalance HEMOSTASIS in hemophilia A and B. In the phase 3 BASIS trial, the monoclonal antibody marstacimab reduced bleeding events, and was generally well tolerated, with no unanticipated side effects. After that: matched-donor allo…
…
continue reading

1
Frequent Routine Primary Care Visits May Lower Costs for Higher-Risk Commercially Insured Adults
15:55
15:55
Play later
Play later
Lists
Like
Liked
15:55On this episode of Managed Care Cast, The American Journal of Managed Care® (AJMC®) speaks with Tory M. Wolff, MBA, an author of a study published in the September 2025 issue and managing partner of Recon Strategy, a management consulting firm specializing in health care strategy.His study, "Impact of More Primary Care Visits on Commercial Health C…
…
continue reading

1
Oral Health Link to Overall Health: Learn It and Teach It to Patients (with Dr. Imran Ahson)
54:54
54:54
Play later
Play later
Lists
Like
Liked
54:54There are major parallels between oral health and overall health, and it is our responsibility, as oral surgeons, to educate our patients about these connections. Today, on Everyday Oral Surgery, Dr. Imran Ahson is joining the conversation. Dr. Ahson’s goal, when speaking publicly, is always to connect oral health with systemic health, and today, h…
…
continue reading

1
Mohammad AZ Al-Ani, MD, FACC, FSCMR - Moving HCM Excellence Into the Fast Lane: Harnessing Technology to Reconfigure Clinical Workflows in an Academic Medical Center
38:40
38:40
Play later
Play later
Lists
Like
Liked
38:40This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/XBK86…
…
continue reading

1
Mohammad AZ Al-Ani, MD, FACC, FSCMR - Moving HCM Excellence Into the Fast Lane: Harnessing Technology to Reconfigure Clinical Workflows in an Academic Medical Center
38:40
38:40
Play later
Play later
Lists
Like
Liked
38:40This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/XBK86…
…
continue reading

1
Dr. Anders Kolb on Leading Blood Cancer United Into a New Era
29:35
29:35
Play later
Play later
Lists
Like
Liked
29:35Dr. Anders Kolb on Leading Blood Cancer United Into a New Era by Managed Care CastBy Managed Care Cast
…
continue reading

1
Epstein-Barr virus genomic variants in human disease states, somatic GATA1 mutations and leukemia in Down syndrome, and new definitions for high-risk multiple myeloma
18:01
18:01
Play later
Play later
Lists
Like
Liked
18:01In this week's episode, we’ll learn more about relationships between Epstein-Barr virus genomic variants and human diseases, including hematological malignancies; the presence and timing of somatic GATA1 mutations and their relationship to a Down syndrome-specific form of leukemia; and new definitions for high-risk multiple myeloma that emphasize t…
…
continue reading

1
020 Myeloma UK at the Heart: Advocacy, Research and Hope
37:47
37:47
Play later
Play later
Lists
Like
Liked
37:47This episode features Dr Sophie Castell, CEO of Myeloma UK, sharing insights into the charity’s vital work in research, advocacy, patient support, and tackling inequalities in myeloma care. 📌Key Takeaways: Survival rates for myeloma have quadrupled — and living well is now as important as living longer. Myeloma UK drives progress from early diagnos…
…
continue reading

1
Breaking Isolation, Building Connection: Suicide Prevention with Helping Heroes USA
43:39
43:39
Play later
Play later
Lists
Like
Liked
43:39Host Dr. Tyler Pieron speaks with Tony DeMaio, founder of Helping Heroes USA, about suicide prevention for veterans and first responders. Tony shares his journey from Project Hero to launching Helping Heroes USA, and how communities—not just professionals—can step up to save lives. Highlights The impact of suicide on families and communities How is…
…
continue reading

1
Practical Implications of Racial Bias in Electronic Health Care Records: Mary Catherine Beach, MD, MPH
18:58
18:58
Play later
Play later
Lists
Like
Liked
18:58On this episode of Managed Care Cast, expert Mary Catherine Beach, MD, MPH, a professor of medicine at the Johns Hopkins University School of Medicine, discusses the practical implications of bias in electronic health care records.By Managed Care Cast
…
continue reading

1
The Four Pillars of Emergency Readiness (with Dr. Richard Marn, MD, Anesthesiologist)
1:05:37
1:05:37
Play later
Play later
Lists
Like
Liked
1:05:37Sedation emergencies may be rare, but when they happen, the consequences can be catastrophic. In this episode, anesthesiologist Dr. Richard Marn shares a practical framework to help oral surgeons prepare for high-stress, low-frequency events that can jeopardize patient safety and derail a practice. Drawing on his work with multiple oral surgeons an…
…
continue reading

1
Oncology Nursing Update: Multiple Myeloma — An Interview with Dr Beth Faiman on CAR T-Cell Therapy
53:08
53:08
Play later
Play later
Lists
Like
Liked
53:08Dr Beth Faiman from Case Comprehensive Cancer Center in Cleveland, Ohio, discusses nursing considerations with CAR T-cell therapy for patients with multiple myeloma. NCPD information and select publications here.
…
continue reading

1
Review Series on Acute Lymphoblastic Leukemia (ALL)
12:38
12:38
Play later
Play later
Lists
Like
Liked
12:38In this Review Series episode, Associate Editor Dr. Hervé Dombret speaks with Dr. Mark Litzow about the latest immunotherapy advances for Acute Lymphoblastic Leukemia (ALL). The discussion highlights innovative treatments like blinatumomab and inotuzumab, which are showing remarkable success in clinical trials, including an 85% three-year survival …
…
continue reading

1
Azacitidine holds promise in VEXAS syndrome; a step forward in precision blood matching; identifying a new vulnerability in TP53-mutated AML
18:58
18:58
Play later
Play later
Lists
Like
Liked
18:58In this week's episode we'll learn about Azacitidine in VEXAS syndrome. Treatment can provide responses in patients with this complex autoinflammatory disorder. But relapse rates were high, so long-term therapy may be required to maintain disease control. After that: A step forward in precision blood matching. High-throughput array genotyping enabl…
…
continue reading

1
Transforming Addiction Care: From Stigma to Support
30:01
30:01
Play later
Play later
Lists
Like
Liked
30:01For National Recovery Month, we are joined by Matthew O. Hurford, MD, vice president, Behavioral Health, UPMC Insurance Services Division, and Michael Lynch, MD, an attending emergency physician and medical toxicologist at UPMC. Among the topics we hit on are the 4 crucial dimensions of recovery; understanding that addiction is a brain disease, not…
…
continue reading

1
Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies: Part 2 — An Interview with Dr Neel Pasricha on Adverse Event Management
54:23
54:23
Play later
Play later
Lists
Like
Liked
54:23Dr Neel Pasricha from the University of California, San Franciso, reviews corneal and other ophthalmic toxicities associated with antibody-drug conjugates and other cancer therapies and strategies for their prevention and management. CME information and select publications here.
…
continue reading

1
Ep 207 Sleep Strategies for Shift Work
1:21:04
1:21:04
Play later
Play later
Lists
Like
Liked
1:21:04Discover evidence-based sleep strategies for shift workers. Optimize performance, recovery, and health with tips from sleep expert Dr. Michael Mak... If you find this beneficial please consider a donation to support EM Cases: https://emergencymedicinecases.com/donation/By Dr. Anton Helman
…
continue reading

1
Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies: Part 1 — Inside the Issue of Adverse Event Management
57:47
57:47
Play later
Play later
Lists
Like
Liked
57:47Prof Rebecca A Dent from National Cancer Centre Singapore, Dr Hans Lee from Sara Cannon Research Institute in Nashville, Tennessee, Dr Neel Pasricha from the University of California, San Francisco, and Dr Tiffany A Richards from The University of Texas MD Anderson Cancer Center in Houston, discuss strategies to manage ocular toxicities associated …
…
continue reading

1
Heme Series: Lymphomas and Multiple Myeloma (with Drs. Andrew Jenzer and Maxwell Lloyd)
51:02
51:02
Play later
Play later
Lists
Like
Liked
51:02In this episode of Everyday Oral Surgery, we continue our Heme Series on all things blood-related by discussing lymphomas and multiple myeloma. Joining Dr. Stucki on the podcast again, to share a wealth of knowledge, are Drs. Andrew Jenzer and Maxwell Lloyd. They delve into a discussion on the basics of lymphomas, dissecting the two categories of H…
…
continue reading

1
Diffuse large B-cell lymphoma’s long-term effects on immune profiles, plasminogen activation and prevention of venous thromboembolism, and PARP inhibitors in hematological malignancies carrying epigenetic ...
18:31
18:31
Play later
Play later
Lists
Like
Liked
18:31In this week's episode we'll learn about persistent changes in immune profiles in patients who have had diffuse large B-cell lymphoma, or DLBCL, and other cancers; that plasminogen activation and plasmin activity do not appear to play a role in routine physiological prevention of venous thromboembolism, or VTE; and about a novel mechanism that make…
…
continue reading

1
Key Decisions for Selecting Bispecific Antibodies in Follicular Lymphoma
22:53
22:53
Play later
Play later
Lists
Like
Liked
22:53In this episode, Dr Christopher Flowers and Dr John Allan discuss their experience with the use of CD20xCD3 bispecific antibodies in the treatment of patients with relapsed/refractory follicular lymphoma. They also their thoughts on key ongoing clinical trials with bispecific antibodies that they are excited about for their potential to change the …
…
continue reading

1
019 Four Drugs, One Goal - A New Option for Older Myeloma Patients
34:38
34:38
Play later
Play later
Lists
Like
Liked
34:38Welcome to The Myeloma Minutes. We've now moved to a fortnightly release schedule, so you can now hear us every-other Thursday. This episode explains the newly approved four-drug treatment (Isatuximab, Velcade, Lenalidomide and Dexamethasone) for older people with myeloma who are not eligible for a stem cell transplant. 📌Key Takeaways: This four-dr…
…
continue reading

1
Navigating the Alzheimer Disease Blood Test Revolution
32:34
32:34
Play later
Play later
Lists
Like
Liked
32:34We discuss the May 16 FDA approval of the first blood test to diagnose Alzheimer disease. This landmark approval marks a significant shift in how Alzheimer disease is identified, moving away from more traditional methods or invasive methods. Our guests, Howard Fillit, the Alzheimer’s Drug Discovery Foundation, and Anthony “Nino” Sireci, MD, MSc, El…
…
continue reading

1
A Day in the Life of Mindy Fast & Mike Kastner | Navigating the Multiple Myeloma Journey
24:23
24:23
Play later
Play later
Lists
Like
Liked
24:23A Day in the Life of Mindy Fast & Mike Kastner | Navigating the Multiple Myeloma Journey by International Myeloma FoundationBy International Myeloma Foundation
…
continue reading

1
Congenitally Missing Lateral Incisors: The Team Approach to Ensuring Success (with Dr. Vic Martel)
48:36
48:36
Play later
Play later
Lists
Like
Liked
48:36Treating congenitally missing lateral incisors is a family and team affair, and it requires stringent protocols to achieve the desired outcome. Dr. Vic Martel, a general dentist in Florida, joins Dr. Stucki on this episode of Everyday Oral Surgery. Their conversation focuses on the interdisciplinary team approach required for successfully treating …
…
continue reading

1
Oncology Nursing Update: Newly Diagnosed Multiple Myeloma — An Interview with Ms Charise Gleason
54:17
54:17
Play later
Play later
Lists
Like
Liked
54:17Ms Charise Gleason from Emory Healthcare in Atlanta, Georgia, discusses the evolution of first-line therapy for patients with multiple myeloma. NCPD information and select publications here.
…
continue reading

1
Oncology Nursing Update: Newly Diagnosed Multiple Myeloma — An Interview with Prof Xavier Leleu
53:08
53:08
Play later
Play later
Lists
Like
Liked
53:08Prof Xavier Leleu from Poitiers University Hospital in Poitiers, France, discusses nursing considerations in the treatment of newly diagnosed multiple myeloma. NCPD information and select publications here.
…
continue reading

1
Pancreatic Cancer Progress: Expert Insights on Treatment Choices and Collaborating with Patients
13:57
13:57
Play later
Play later
Lists
Like
Liked
13:57Listen in as Zev A. Wainberg, MD; Paul E. Oberstein, MD; and Mark O’Hara, MD, discuss the evolving treatment landscape for metastatic pancreatic cancer, including: How patients often present with disease-related symptoms Treatment selection considerations for the first-line and second-line setting How to approach palliative care discussions with pa…
…
continue reading

1
“Ironing out” Tet2-mutant HSPCs; A CAR-T “license to kill” in T cell leukemia/lymphoma; insights on cHL genetics, through the lens of ctDNA
20:43
20:43
Play later
Play later
Lists
Like
Liked
20:43In this week's episode, we'll learn about how TET2 is often mutated in myeloid malignancies and clonal hematopoiesis. In new work, expansion of Tet2-mutant HSPCs was dependent on Ncoa4, the cargo receptor mediating ferritinophagy. We’ll iron out the implications. After that: a double-oh-seven license to kill in T-cell leukemia/lymphoma. WU-CART-007…
…
continue reading

1
Latest Advances in CAR T-Cell Therapy for Lymphomas and Multiple Myeloma
16:48
16:48
Play later
Play later
Lists
Like
Liked
16:48In this episode, Dr Brad Kahl and Dr Noopur Raje discuss the recent advances and emerging data for CAR T-cell therapy in lymphomas and multiple myeloma including the latest evidence from long-term clinical trial follow-up and real-world data, plus new data with CAR T-cell therapies in new lymphoma settings and novel CAR T-cell therapies currently u…
…
continue reading

1
AI in Health Care: Balancing Governance, Innovation, and Trust
16:20
16:20
Play later
Play later
Lists
Like
Liked
16:20Committed to building safe, reliable, and value-driven AI solutions that enhance health care delivery and the member experience, UPMC Health Plan's approach to AI is grounded in strong governance, balancing innovation with critical ethical concerns. In this conversation, we dive into how UPMC Health Plan builds trust with providers and members, dis…
…
continue reading

1
Sarah Cuddy, MD / Ronald Witteles, MD - Expert Perspectives on Novel Approaches to Therapy for ATTR Cardiac Amyloidosis
35:05
35:05
Play later
Play later
Lists
Like
Liked
35:05This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/YFD865. CME credit will…
…
continue reading

1
Sarah Cuddy, MD / Ronald Witteles, MD - Expert Perspectives on Novel Approaches to Therapy for ATTR Cardiac Amyloidosis
35:05
35:05
Play later
Play later
Lists
Like
Liked
35:05This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/YFD865. CME credit will…
…
continue reading

1
The Implant Treatment Coordinator: Their Purpose and Specific Functions (with Dr. Roger Levin)
52:02
52:02
Play later
Play later
Lists
Like
Liked
52:02An implant treatment coordinator is the secret weapon to growing your implant referrals. In this episode of Every Day Oral Surgery, Dr. Roger Levin of the Levin Group joins Dr. Stucki again to reveal why the implant treatment coordinator’s (ITC) role is essential and how to set them up for success. Tuning in, you’ll hear what the ITC needs to do be…
…
continue reading
On today’s episode of ‘Wait, How Do You Spell That? A Rare Disease podcast brought to you by Patient Worthy. We are thrilled to share with you a story that is as powerful as it is inspiring. Our guest today is Lisa Batista, author of the newly released memoir, "Falling: A Journey of Strength, Survival and Rising," which is now available on Amazon, …
…
continue reading

1
Relapsed/Refractory Multiple Myeloma — Oncology Q&A: Discussing Common Questions Posed by Patients
59:21
59:21
Play later
Play later
Lists
Like
Liked
59:21Dr Natalie S Callander and Dr Sagar Lonial provide clinical perspectives on the treatment and disease-management course for patients with relapsed/refractory multiple myeloma. CME information and select publications here.
…
continue reading